Huang Wen-Hai, Zhou Min-Wei, Zhu Yan-Feng, Xiang Jian-Bin, Li Zhen-Yang, Wang Zi-Hao, Zhou Yi-Ming, Yang Yi, Chen Zong-You, Gu Xiao-Dong
Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Department of Nursing, Huashan Hospital, Fudan University, Shanghai 200040, People's Republic of China.
Onco Targets Ther. 2019 Sep 16;12:7573-7580. doi: 10.2147/OTT.S214409. eCollection 2019.
Colorectal cancer (CRC) is the most common malignancy in the gastrointestinal tract. The liver is the most common location of CRC metastases, which are the main causes of CRC-related death. However, the mechanisms underlying metastasis of CRC to the liver have not been characterized, resulting in therapeutic challenges.
The effects of hepatic stellate cells (HSCs) on T cells were evaluated using in vitro mixed lymphocyte reactions (MLRs) and cytokine production assays. HSC-induced CT26 cell migration and proliferation were evaluated in vitro and in vivo.
HSCs induced T cell hypo-responsiveness, promoted T cell apoptosis, and induced regulatory T cell expansion in vitro. IL-2 and IL-4 were significantly lower in MLRs incubated with HSCs. Supernatants of MLRs with HSCs promoted CT26 cell proliferation and migration. Furthermore, the presence of HSCs increased the number of liver metastases and promoted proliferation of liver metastatic tumor cells in vivo.
HSCs may contribute to an immunosuppressive liver microenvironment, resulting in a favorable environment for the colonization of CRC cells in the liver. These findings highlight a potential strategy for treatment of CRC liver metastases.
结直肠癌(CRC)是胃肠道最常见的恶性肿瘤。肝脏是CRC转移最常见的部位,是CRC相关死亡的主要原因。然而,CRC转移至肝脏的潜在机制尚未明确,导致治疗面临挑战。
使用体外混合淋巴细胞反应(MLR)和细胞因子产生试验评估肝星状细胞(HSC)对T细胞的影响。在体外和体内评估HSC诱导的CT26细胞迁移和增殖。
HSC在体外诱导T细胞低反应性,促进T细胞凋亡,并诱导调节性T细胞扩增。与HSC共孵育的MLR中IL-2和IL-4显著降低。含HSC的MLR上清液促进CT26细胞增殖和迁移。此外,HSC的存在增加了肝转移灶数量,并促进体内肝转移肿瘤细胞的增殖。
HSC可能促成免疫抑制性肝微环境,为CRC细胞在肝脏定植创造有利环境。这些发现凸显了一种治疗CRC肝转移的潜在策略。